These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37864740)

  • 1. COVID-19 + Cirrhosis = Excess Hospital Confinement, Excess Casualties.
    Gonzalez HC; Trudeau S
    Dig Dis Sci; 2023 Dec; 68(12):4290-4291. PubMed ID: 37864740
    [No Abstract]   [Full Text] [Related]  

  • 2. Most excess years of potential life loss among individuals with cirrhosis during the pandemic were not related to COVID-19.
    Zhao Y; Yeo YH; Samaan J; Lv F; He X; Gao N; Park J; Yang JD; Ayoub W; Odden MC; Ji F; Nguyen MH
    Gut; 2023 Aug; 72(8):1628-1630. PubMed ID: 36282906
    [No Abstract]   [Full Text] [Related]  

  • 3. Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study.
    Afify S; Eysa B; Hamid FA; Abo-Elazm OM; Edris MA; Maher R; Abdelhalim A; Abdel Ghaffar MM; Omran DA; Shousha HI
    World J Gastroenterol; 2021 Nov; 27(42):7362-7375. PubMed ID: 34876795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rates of timely paracentesis for patients admitted to hospital with cirrhosis and ascites remain low but are unaffected by the COVID-19 pandemic.
    Aby ES; Lall D; Vasdev A; Mayer A; Olson APJ; Lim N
    J Hosp Med; 2022 Apr; 17(4):276-280. PubMed ID: 35535925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and outcomes for acute-on-chronic liver failure in COVID-19: a large multi-center observational cohort study.
    Satapathy SK; Roth NC; Kvasnovsky C; Hirsch JS; Trindade AJ; Molmenti E; Barish M; Hirschwerk D; Da BL; Bernstein D;
    Hepatol Int; 2021 Jun; 15(3):766-779. PubMed ID: 33826042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative impact of the pandemic on hospital admissions, morbidity and early mortality for acute cirrhosis decompensation.
    Gananandan K; Phillips A; Chikhlia A; Old H; Sim SJY; Thakur N; Hussain I; Kazankov K; Mookerjee RP
    BMJ Open Gastroenterol; 2023 Jan; 10(1):. PubMed ID: 36650007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the COVID-19 pandemic on patients with liver cirrhosis-the experience of a tertiary center in Germany.
    Höner Zu Siederdissen C; Schultalbers M; Wübbolding M; Lechte GS; Laser H; Cornberg M; Wedemeyer H; Maasoumy B
    Z Gastroenterol; 2021 Sep; 59(9):954-960. PubMed ID: 34507374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excess Deaths of Gastrointestinal, Liver, and Pancreatic Diseases During the COVID-19 Pandemic in the United States.
    Han L; Shi H; Li Y; Qi H; Wang Y; Gu J; Wu J; Zhao S; Cao P; Xu L; Deng X; Yao XI; Ran J
    Int J Public Health; 2023; 68():1606305. PubMed ID: 37649691
    [No Abstract]   [Full Text] [Related]  

  • 9. Racial and Ethnic Disparities in Years of Potential Life Loss Among Patients With Cirrhosis During the COVID-19 Pandemic in the United States.
    Zhao Y; Yeo YH; Samaan J; Lv F; He X; Liu J; Li M; Gao N; Park J; Yang JD; Ayoub WS; Zhang L; Odden MC; Ji F; Nguyen MH
    Am J Gastroenterol; 2023 Apr; 118(4):752-757. PubMed ID: 36728136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020.
    Mallet V; Beeker N; Bouam S; Sogni P; Pol S;
    J Hepatol; 2021 Oct; 75(4):848-855. PubMed ID: 33992699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of liver biochemical abnormality between COVID-19 patients with liver cirrhosis versus COVID-19 alone and liver cirrhosis alone: A STROBE observational study.
    An Y; Ma Z; Guo X; Tang Y; Meng H; Yu H; Peng C; Chu G; Wang X; Teng Y; Zhang Q; Zhu T; Wang B; Tong Z; Zhao H; Lu H; Qi X
    Medicine (Baltimore); 2021 May; 100(19):e25497. PubMed ID: 34106589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical course of COVID-19 in patients with pre-existing decompensated cirrhosis: initial report from China.
    Qi X; Wang J; Li X; Wang Z; Liu Y; Yang H; Li X; Shi J; Xiang H; Liu T; Kawada N; Maruyama H; Jiang Z; Wang F; Takehara T; Rockey DC; Sarin SK;
    Hepatol Int; 2020 Jul; 14(4):478-482. PubMed ID: 32440857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Child-Pugh and CRUB65 scores predict mortality of decompensated cirrhosis patients with COVID-19: A 23-center, retrospective study.
    Xiao Y; Wu D; Shi X; Liu S; Hu X; Zhou C; Tian X; Liu H; Long H; Li Z; Wang J; Tan T; Xu Y; Chen B; Liu T; Zhang H; Zheng S; Hu S; Song J; Tang J; Song J; Cheng Z; Xu W; Shen Y; Yu W; Xu Y; Li J; Zhou J; Wang F; Chen M
    Virulence; 2021 Dec; 12(1):1199-1208. PubMed ID: 33870852
    [No Abstract]   [Full Text] [Related]  

  • 14. Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, Before and During COVID-19 Pandemic.
    Kim D; Bonham CA; Konyn P; Cholankeril G; Ahmed A
    Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2664-2666.e2. PubMed ID: 34256143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 mortality in cirrhosis is determined by cirrhosis-associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry.
    Brozat JF; Hanses F; Haelberger M; Stecher M; Dreher M; Tometten L; Ruethrich MM; Vehreschild JJ; Trautwein C; Borgmann S; Vehreschild MJGT; Jakob CEM; Stallmach A; Wille K; Hellwig K; Isberner N; Reuken PA; Geisler F; Nattermann J; Bruns T;
    United European Gastroenterol J; 2022 May; 10(4):409-424. PubMed ID: 35482663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of SARS CoV-2 /COVID-19 infection on the course of advanced chronic liver disease and hepatocellular carcinoma.
    Pazgan-Simon M; Kucharska M; Górka-Dynysiewicz J; Simon K
    Pharmacol Rep; 2022 Dec; 74(6):1306-1314. PubMed ID: 36394820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor outcomes in patients with cirrhosis and Corona Virus Disease-19.
    Shalimar ; Elhence A; Vaishnav M; Kumar R; Pathak P; Soni KD; Aggarwal R; Soneja M; Jorwal P; Kumar A; Khanna P; Singh AK; Biswas A; Nischal N; Dar L; Choudhary A; Rangarajan K; Mohan A; Acharya P; Nayak B; Gunjan D; Saraya A; Mahapatra S; Makharia G; Trikha A; Garg P
    Indian J Gastroenterol; 2020 Jun; 39(3):285-291. PubMed ID: 32803716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High rates of 30-day mortality in patients with cirrhosis and COVID-19.
    Iavarone M; D'Ambrosio R; Soria A; Triolo M; Pugliese N; Del Poggio P; Perricone G; Massironi S; Spinetti A; Buscarini E; Viganò M; Carriero C; Fagiuoli S; Aghemo A; Belli LS; Lucà M; Pedaci M; Rimondi A; Rumi MG; Invernizzi P; Bonfanti P; Lampertico P
    J Hepatol; 2020 Nov; 73(5):1063-1071. PubMed ID: 32526252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort.
    Bajaj JS; Garcia-Tsao G; Biggins SW; Kamath PS; Wong F; McGeorge S; Shaw J; Pearson M; Chew M; Fagan A; de la Rosa Rodriguez R; Worthington J; Olofson A; Weir V; Trisolini C; Dwyer S; Reddy KR
    Gut; 2021 Mar; 70(3):531-536. PubMed ID: 32660964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic Predictors of Mortality in Severe Acute Respiratory Syndrome Coronavirus 2: Role of Initial Aspartate Aminotransferase/Alanine Aminotransferase and Preexisting Cirrhosis.
    Frager SZ; Szymanski J; Schwartz JM; Massoumi HS; Kinkhabwala M; Wolkoff AW
    Hepatol Commun; 2021 Mar; 5(3):424-433. PubMed ID: 33681677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.